Clearance from Dialysate and Equilibration of Intraperitoneal Vancomycin in Continuous Ambulatory Peritoneal Dialysis
- 1 June 1990
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 18 (6) , 485-490
- https://doi.org/10.2165/00003088-199018060-00005
Abstract
This article reports on a study of the disposition of loading doses (1g and 15 mg/kg) of vancomycin given intraperitoneally to 6 patients on continuous ambulatory peritoneal dialysis with Gram-positive peritonitis. Dialysate samples were collected every 30 minutes during the first dwell, and serum samples were collected after the first 5 exchanges and after 7 or 14 days. The dialysate concentration/time data were fitted to a monoexponential curve for 4 patients and to a biexponential curve for 2 others. Dialysis clearance was 0.73 ± 0.04 L/h (1g dose) and 0.70 ± 0.23 L/h (15 mg/kg dose). Total body clearance was 0.51 ± 0.36 L/h. Serum concentrations reached 14 to 18 mg/L (15 mg/kg dose) and 6.75 to 24 mg/L (1g dose) at the end of the first dwell. The half-life of equilibration of vancomycin across the peritoneal membrane was 2.5 ± 2.3 hours. Intraperitoneal loading doses of vancomycin produce concomitant serum concentrations in excess of the minimum inhibitory concentrations for susceptible organisms. Administration on a milligram per kilogram basis produces more consistent serum concentrations than using a standard loading dose which is not based on bodyweight.This publication has 14 references indexed in Scilit:
- Intraperitoneal (IP) Vancomycin Therapy for CAPI) Peritonitis—A Prospective, Randomized Comparison of Intermittent v Continuous TherapyAmerican Journal of Kidney Diseases, 1988
- Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis. Report of a working party of the British Society for Antimicrobial Chemotherapy.1987
- Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysisAntimicrobial Agents and Chemotherapy, 1987
- Intravenous or Intraperitoneal Vancomycin for the Treatment of Continuous Ambulatory Peritoneal Dialysis Associated Gram-Positive Peritonitis?Nephron, 1987
- Vancomycin Pharmacokinetics in Continuous Ambulatory Peritoneal Dialysis Patients with PeritonitisNephron, 1986
- Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transportAntimicrobial Agents and Chemotherapy, 1985
- Vancomycin kinetics during continuous ambulatory peritoneal dialysisClinical Pharmacology & Therapeutics, 1983
- Peritonitis in Continuous Ambulatory Peritoneal Dialysis PatientsAmerican Journal of Kidney Diseases, 1983
- Peritoneal Transport of Vancomycin in 4 Patients Undergoing Continuous Ambulatory Peritoneal DialysisNephron, 1982
- Sensitive Bioassay for VancomycinAntimicrobial Agents and Chemotherapy, 1978